Article

Warning Signs

Tips for knowing what online information to trust. 

It may not be easy to know what online information to trust. Even some reputable websites may fall short in certain areas. A helpful way to assess a website is to look closely at what’s there and what isn’t.

The U.S. Federal Trade Commission has developed a list of claims that should make you suspicious of a website:

> Claims of a “scientific breakthrough,” “miraculous cure,” “secret ingredient,” or “ancient remedy.”

> Claims that a product can cure a wide range of illnesses. No single product can do this.

> Case histories of people who have had amazing results but no clear scientific data are available.

> Claims that a product is available only from one source, especially if payment is required in advance.

> Claims of a “money-back” guarantee.

> Websites that do not list the company’s name, physical address, phone number, or other important contact information.

Problems in any of these areas should raise a red flag to the user that the website may have scientifically inaccurate information. This may be especially important when looking at sites promoting complementary or alternative cancer treatments.

Adapted with permission of the American Cancer Society

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content